Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
about
Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasomeThe Role of TLR2, TLR4, and TLR9 in the Pathogenesis of AtherosclerosisChlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice.Chronic infections and atherosclerosis/thrombosis.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureT helper type 1 lymphocytes drive inflammation in human atherosclerotic lesionsMatrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.Vaccination and atherosclerosis.Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?Immunomodulation and vaccination for atherosclerosis.Myocarditis, microbes and autoimmunity.Development potential of rifalazil and other benzoxazinorifamycins.Innate immunity, macrophage activation, and atherosclerosis.Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.Infections and autoimmunity: a panorama.TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J micePossibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells.Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat modelMolecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).The immune system in atherosclerosis and in acute myocardial infarction.Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.The immunology of atherosclerosis.HLA, infections and inflammation in early stages of atherosclerosis in children with type 1 diabetes.Microbial modulation of cardiovascular disease.Chlamydia pneumoniae and Cardiovascular Disease.The Role of Gut Microbiota in Atherosclerosis and Hypertension
P2860
Q27027451-702C87A6-AEF5-4FF3-A037-C6093A77446BQ28077737-5CDE7B76-3AAB-43B7-A36B-36B306AFC4AEQ34130686-070FE815-83C8-443E-80F2-20DBB6787260Q34514051-BEDDF6AE-2A4F-4BB8-AFAB-9E024EF090ECQ35127516-28FEB2CD-E4F9-4F93-9C4E-5B7195EAC5E8Q35143874-A4F9E2CD-3F1A-45FD-9FFC-95435852B1EEQ35583908-0E118F2E-AA07-45F7-B2A3-57FD0B1012A9Q35692035-81B57EAE-7329-4889-BB6F-5CFCECA3BC46Q35701591-3EACCE71-8D5D-4C70-9732-5E0B3262F68AQ35753555-C8CF8939-B96D-49C3-A0F2-659D3F72F349Q35994765-E1FD1DB6-B8CC-469C-B81C-D5EDC1060691Q36491823-6CAD00A5-F24A-4F71-BAFE-01ED8F0237BEQ36938635-DDD48D68-43E0-439B-9C39-23CF475FFC68Q36958999-DC94F4C3-7119-49C0-981E-789C9265D803Q37071664-9A9378F3-16A1-47F1-800D-9F2B04056223Q37196471-4F7860D8-4DB9-4383-AD0F-84AB6E05A14DQ37568474-A2370636-1072-4BB3-AC3D-11DC050B6116Q37775097-524E0077-B33E-4C60-AE4B-E851A1FFED23Q37864081-8AD2215D-C99C-4D32-A4F4-BBE4DF003AC1Q37868385-82353081-2704-42E7-969F-07103C8F7648Q37870924-001D30A0-2CF2-463C-A7AF-FB65DED6B7BAQ38605504-61CF042C-AB06-4F6D-9622-6A9E9819593BQ38781034-946746A9-7B68-4268-8AE9-FB95974AA4E4Q39230390-2F2AFB67-EEC6-41C8-A1F9-CB6B3194CF4DQ47734445-265B034D-F735-414D-AF8A-5178237FB5C6Q50144047-DB5817DF-7FBA-4823-88A4-F27146E721CFQ51726841-89183DDF-4723-4117-93F3-098CAE028A78Q57492139-97EBA577-D17C-4B9C-9FB9-92FDA94D8B94
P2860
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@en
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@nl
type
label
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@en
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@nl
prefLabel
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@en
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@nl
P2093
P1433
P1476
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
@en
P2093
Caligiuri G
Hansson GK
Nicoletti A
Rottenberg M
P304
P356
10.1161/01.CIR.103.23.2834
P407
P50
P577
2001-06-01T00:00:00Z